Bulged DNA Substrates for Identifying Poxvirus Resolvase Inhibitors


Matthew Culyba, Young Hwang, Sana Attar, Peter B. Madrid, James Bupp, Donna Huryn, Luis Sanchez, Jay Grobler, Michael D. Miller, Frederic D. Bushman, Bulged DNA substrates for identifying poxvirus resolvase inhibitors, Nucleic Acids Research, Volume 40, Issue 16, 1 September 2012, Page e124, https://doi.org/10.1093/nar/gks325


Resolvase enzymes that cleave DNA four-way (Holliday) junctions are required for poxvirus replication, but clinically useful inhibitors have not been developed. Here, we report an assay for resolvase cleavage activity based on fluorescence polarization (FP) for high-throughput screening and mechanistic studies. Initial analysis showed that cleavage of a fluorescently labeled Holliday junction substrate did not yield an appreciable change in FP, probably because the cleavage product did not have sufficiently increased mobility to yield a strong FP signal. Iterative optimization yielded a substrate with an off-center DNA bulge, which after cleavage released a labeled short stand and yielded a greatly reduced FP signal. Using this assay, 133 000 compounds were screened, identifying 1-hydroxy-1,8-naphthyridin-2(1H)-one compounds as inhibitors. Structure-activity studies revealed functional parallels to Food and Drug Administration (FDA)-approved drugs targeting the related human immunodeficiency virus integrase enzyme. Some 1-hydroxy-1,8-naphthyridin-2(1H)-one compounds showed anti-poxvirus activity.

Read more from SRI